文献速递重症综合管理与镇静镇痛心脑血管急症

静脉-动脉体外膜氧合成功撤机的相关参数:系统综述

Parameters associated with successful weaning of veno-arterial extracorporeal membrane oxygenation: a systematic review.
PubMed 文献 · Crit Care · 2022-12-05
一句话结论成人心源性休克VA-ECMO撤机需综合生物标志物、血流动力学和超声参数,左室流出道速度时间积分是最常用指标。

该系统综述纳入47项原始研究,旨在确定与成人心源性休克VA-ECMO成功撤机相关的生物标志物、血流动力学和超声心动图参数,并据此提出基于证据的撤机流程。结果显示,初始休克和心肌损伤程度较轻、全身灌注早期恢复、左右心室功能恢复、流量递减试验和/或泵控逆行撤机试验期间血流动力学和超声心动图稳定,均预示成功撤机;最广泛使用的参数是左室流出道速度时间积分。多数研究存在中等或高偏倚风险,方法、测量时机和条件异质性大,无法进行meta分析。

要点

  • 初始休克和心肌损伤程度较轻(生物标志物)预示VA-ECMO成功撤机。
  • 全身灌注早期恢复、左右心室功能恢复预示成功撤机。
  • 流量递减试验和/或泵控逆行撤机试验期间血流动力学和超声心动图稳定预示成功撤机。
  • 左室流出道速度时间积分是预测撤机最广泛使用的参数,反映每搏输出量。
  • 多数研究偏倚风险中等或高,方法异质性大致无法meta分析。

适用人群与场景

  • 成人心源性休克接受VA-ECMO的患者;排除仅限体外心肺复苏(ECPR)的研究,因神经预后可能显著改变撤机决策;排除仅以VAD或心脏移植为桥接的患者,因此类患者按定义从未「成功撤机」;纳入VA-ECMO用于心源性休克或心脏骤停的混合人群研究。

处置流程与药物剂量

  • 基于证据的撤机流程整合关键发现:通过生物标志物、血流动力学和超声心动图参数追踪全身低灌注缓解和心肌恢复,以识别可成功撤机的患者;具体参数包括初始休克和心肌损伤程度较轻、全身灌注早期恢复、左右心室功能恢复、流量递减试验和/或泵控逆行撤机试验期间血流动力学和超声心动图稳定;最广泛使用的参数为左室流出道速度时间积分。

研究设计与关键结果

  • 系统综述纳入47项原始研究(筛选14,578条记录),采用非随机研究偏倚风险评估工具,研究注册于PROSPERO CRD42020178641。
  • 初始休克和心肌损伤程度较轻、全身灌注早期恢复、左右心室功能恢复、流量递减试验和/或泵控逆行撤机试验期间血流动力学和超声心动图稳定,均预示成功撤机。
  • 最广泛使用的参数是左室流出道速度时间积分,为每搏输出量的指标。
  • 多数研究偏倚风险中等或高;方法、测量时机和条件的异质性妨碍了meta分析。

证据类型、等级与局限

  • 证据类型:系统综述(PROSPERO CRD42020178641),纳入47项原始研究,采用非随机研究偏倚风险评估工具。
  • 局限:多数研究偏倚风险中等或高;方法、测量时机和条件的异质性妨碍了meta分析。

对床旁实践的改变

  • 在成人心源性休克VA-ECMO患者中,可采用多种生物标志物、血流动力学和超声心动图参数追踪全身低灌注缓解和心肌恢复,以识别可成功撤机的患者(作者认为)。
  • 最广泛使用的撤机预测参数是左室流出道速度时间积分(每搏输出量指标)。
  • 流量递减试验和/或泵控逆行撤机试验期间血流动力学和超声心动图稳定提示成功撤机。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) can be used to restore organ perfusion in patients with cardiogenic shock until native heart recovery occurs. It may be challenging, however, to determine when patients can be weaned successfully from ECMO-surviving without requiring further mechanical support or heart transplant. We aimed to systematically review the medical literature to determine the biomarkers, hemodynamic and echocardiographic parameters associated with successful weaning of VA-ECMO in adults with cardiogenic shock and to present an evidence-based weaning algorithm incorporating key findings.

METHOD: We systematically searched PubMed, Embase, ProQuest, Google Scholars, Web of Science and the Grey literature for pertinent original research reports. We excluded studies limited to extracorporeal cardiopulmonary resuscitation (ECPR) as the neurological prognosis may significantly alter the decision-making process surrounding the device removal in this patient population. Studies with a mixed population of VA-ECMO for cardiogenic shock or cardiac arrest were included. We excluded studies limited to patients in which ECMO was only used as a bridge to VAD or heart transplant, as such patients are, by definition, never "successfully weaned." We used the Risk of Bias Assessment tool for Non-Randomized Studies. The study was registered on the International prospective register of systematic reviews (PROSPERO CRD42020178641).

RESULTS: We screened 14,578 records and included 47 that met our pre-specified criteria. Signs of lower initial severity of shock and myocardial injury, early recovery of systemic perfusion, left and right ventricular recovery, hemodynamic and echocardiographic stability during flow reduction trial and/or pump-controlled retrograde trial off predicted successful weaning. The most widely used parameter was the left ventricular outflow tract velocity time integral, an indicator of stroke volume. Most studies had a moderate or high risk of bias. Heterogeneity in methods, timing, and conditions of measurements precluded any meta-analysis.

CONCLUSIONS: In adult patients on VA-ECMO for cardiogenic shock, multiple biomarkers, hemodynamic and echocardiographic parameters may be used to track resolution of systemic hypoperfusion and myocardial recovery in order to identify patients that can be successfully weaned.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Charbonneau F, Chahinian K, Bebawi E, et al. Parameters associated with successful weaning of veno-arterial extracorporeal membrane oxygenation: a systematic review. Crit Care. 2022. PMID: 36471408. doi:10.1186/s13054-022-04249-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。